Find out about Anvisa's priorities for the next biennium
RDC 753 - New Regulatory Framework for the Registration of Synthetic Drugs.
WHAT ARE THE STEPS FOR OBTAINING AUTHORIZATION FOR CLINICAL STUDIES IN BRAZIL?
Important circumstances for the submission of drug registration in Brazil
What is the purpose of registration submission guide, based on data from scientific literature?
Biological and biosimilar medicines - development and commercialization challenges
Pharmaceutical Industry – focused on the future
ANVISA – Post-pandemic challenges and perspectives.
Clinical research in Brazil - regulation is important and urgent!